Klinefelter综合征的睾酮替代治疗——随访研究关联止血与RNA表达
该研究纳入未治疗和治疗中的Klinefelter综合征(KS)男性并与健康对照匹配,随访18个月评估睾酮替代治疗(TRT)对止血的影响。结果显示KS整体不伴高凝状态,但存在与较高体脂和纤维蛋白原相关的纤维蛋白溶解受损;18个月TRT与体脂和纤维蛋白原降低相关,减弱促血栓特征,ENPP4表达在KS中较高。
要点
- KS整体不伴高凝状态,但存在纤维蛋白溶解受损。
- 纤维蛋白溶解受损与较高体脂和较高纤维蛋白原水平相关。
- 18个月TRT与体脂和纤维蛋白原降低相关,减弱促血栓特征。
核心结论
- KS与特定表达谱相关,该表达谱促发纤维蛋白溶解受损并增加患者血栓风险。
- KS患者接受TRT有减轻促血栓表型的潜力,尤其通过降低体脂和纤维蛋白原。
研究设计与样本
- 纳入未治疗和治疗中的Klinefelter综合征男性,基线时与健康对照匹配。
- 在未治疗的KS中启动TRT,所有组随访18个月后重新评估。
- 评估凝血酶生成(加或不加血栓调节蛋白)和纤维蛋白凝块溶解(浊度法)。
- 在TRT治疗的KS患者和对照的血液、脂肪和肌肉组织中评估RNA表达。
主要发现
- 加血栓调节蛋白的凝血酶生成在未治疗KS中轻度增加,但KS整体不伴高凝状态。
- KS表现为纤维蛋白溶解受损,与较高体脂和较高纤维蛋白原水平相关。
- KS接受18个月TRT与体脂和纤维蛋白原降低相关,减弱促血栓特征。
- ENPP4表达在KS男性中较高,在纤维蛋白溶解受损相关基因群中起关键作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Men with Klinefelter syndrome (KS) develop hypergonadotropic hypogonadism, are in need of testosterone replacement therapy (TRT), and present with a more than 4-fold increased risk of thrombosis. TRT in KS has the potential to modify thrombotic risk, but data are scarce. AIM: To assess effects of 18 months of TRT on hemostasis in KS and identify genes associated with the prothrombotic phenotype. METHODS: Untreated and TRT-treated men with KS were included at baseline and matched to healthy controls. TRT was initiated in untreated KS and all groups were reassessed after 18 months of follow-up. Thrombin generation was evaluated with or without thrombomodulin, and fibrin clot lysis was evaluated by turbidity measurements. RNA expression was assessed in blood, fat, and muscle tissue of patients with TRT-treated KS and controls. RESULTS: Thrombin generation with thrombomodulin was slightly increased in untreated KS, but overall KS was not associated with a hypercoagulable state. KS presented with fibrinolytic impairment associated with higher body fat and higher levels of fibrinogen. Eighteen months of TRT in KS was associated with a reduction in body fat and fibrinogen, attenuating the prothrombotic profile. The expression of ENPP4 was higher in men with KS and served as a key player among a group of genes associated with impaired fibrinolysis. CONCLUSION: KS is associated with a specific expression profile contributing to fibrinolytic impairment and increased thrombotic risk in the patients. TRT in patients with KS has the potential for alleviating the prothrombotic phenotype, in particular by reducing body fat and fibrinogen.
引用
- Chang S, Just J, Skakkebæk A, et al. Testosterone Replacement Therapy in Klinefelter Syndrome-Follow-up Study Associating Hemostasis and RNA Expression. J Clin Endocrinol Metab. 2024. PMID: 37962976. doi:10.1210/clinem/dgad658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。